Prot# NU 06H2: A Multicenter Phase II Study Incorporating DOXIL® and Rituximab into the Magrath Regimen for HIV-Negative and HIV-Positive Patients with Newly Diagnosed Burkitt's and Burkitt-like Lymphoma

Project: Research project

Project Details

StatusFinished
Effective start/end date8/3/064/1/12

Funding

  • Ortho Biotech Clinical Affairs, LLC (NU 06H2)